全球胃腸道產品市場:按設備、疾病和最終用戶分類 - 預測(截至 2029 年)
市場調查報告書
商品編碼
1546369

全球胃腸道產品市場:按設備、疾病和最終用戶分類 - 預測(截至 2029 年)

Gastrointestinal Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), (Gastrointestinal cancer), End-User (Hospitals, ASC) - Forecast to 2029

出版日期: | 出版商: MarketsandMarkets | 英文 375 Pages | 訂單完成後即時交付

價格

全球胃腸道產品市場規模預計將從2024年的147億美元增加至2029年的197億美元,2024年至2029年複合年成長率為6.1%。

該市場的推動因素包括胃腸道疾病的日益流行、技術的進步、人口老化、醫療保健成本的上升、意識和篩檢工作的增加、研發成本的增加、個人化醫療的需求以及全球等因素驅動的新興市場經濟。由於這些因素的綜合影響,胃腸道產品產業持續充滿活力並不斷發展。

調查範圍
調查年份 2021-2029
基準年 2023年
預測期 2024-2029
單元 10億美元
部分 按設備、按疾病、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

“按設備分類,內視鏡領域將在預測期內佔據最大佔有率。”

內視鏡技術可達到息肉切除、組織切片檢查、支架置入和腫瘤切除等治療和診斷。這些發展增加了內視鏡檢查在各種胃腸道疾病的應用。

“按疾病分類,GERD 部分在預測期內將佔最大佔有率。”

由於生活方式因素、肥胖、人口老化以及診斷/治療方案的改進,胃食道逆流(GERD)盛行率不斷增加,正在顯著推動胃腸病學市場佔有率的成長。隨著人們意識的提高和技術的不斷進步,對胃腸產品服務的需求預計將增加,進一步推動市場成長。隨著全球人口老化,GERD 的盛行率不斷增加。由於食道運動和下食道括約肌功能的變化,老年人更容易罹患胃食道逆流症。

“預計亞太地區在預測期內的複合年成長率最高。”

隨著人口老化,包括日本、韓國和中國在內的許多亞太國家正在經歷人口變化。老年人患有胃食道逆流(GERD)等疾病的比例很高,且醫療需求也很複雜。

本報告研究和分析了全球胃腸道產品市場,提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

  • 胃腸道產品市場概況
  • 亞太地區胃腸道產品市場:按設備、按地區分類(2023 年)
  • 胃腸道產品市場的地理簡介

第5章市場概況

  • 介紹
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
  • 產業趨勢
  • 技術分析
    • 主要技術
    • 互補技術
    • 鄰近技術
  • 價值鏈分析
  • 波特五力分析
  • 監管環境
    • 監管分析
    • 監管機構、政府機構和其他組織
  • 專利分析
  • 貿易分析
    • HS編碼:消化設備
    • 導入資料
    • 匯出資料
  • 價格分析
  • 報銷分析
  • 重大會議和活動(2024-2025)
  • 主要相關利益者和採購標準
  • 未滿足需求分析
  • 最終用戶的期望
  • 生態系分析
  • 案例研究分析
  • 供應鏈分析
  • 投資金籌措場景
  • 生成式AI/AI對胃腸道產品市場的影響

第6章胃腸道產品市場:依設備分類

  • 介紹
  • 內視鏡裝置
    • 軟式內視鏡
    • 硬式內視鏡
    • 膠囊內視鏡
    • 其他內視鏡設備
  • 消融裝置
    • 射頻消融術裝置
    • 微波消融裝置
    • 冷凍裝置
    • 雷射消熔裝置
    • 其他消融裝置
  • 運動測試裝置
    • 食道壓力測量裝置
    • 24小時PH電阻測試裝置
    • 肛門壓力測量裝置
    • 其他運動測試設備
  • 切片檢查裝置
    • 針吸切片裝置
    • 其他切片檢查裝置
  • 支架裝置
    • 膽管支架
    • 結腸支架
    • 十二指腸支架
    • 胰臟支架
    • 食道支架
  • PH監測裝置
    • 食道PH監測導管
    • 無線PH監測膠囊
    • 攜帶式PH監測系統
  • 其他消化相關設備
    • 胃內球囊
    • 消化管
    • 痔瘡治療儀

第7章 胃腸相關產品市場:依疾病分類

  • 介紹
  • 消化道癌症
  • 胃食道逆流症
  • 大腸激躁症(IBS)
  • 發炎性腸道疾病(IBD)
  • 其他疾病

第8章胃腸相關產品市場:依最終用戶分類

  • 介紹
  • 醫院
  • 門診手術中心/獨立手術中心
  • 診所
  • 其他最終用戶

第9章胃腸道產品市場:按地區

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東/非洲
    • 中東和非洲宏觀經濟前景
    • 海灣合作理事會國家
    • 其他中東/非洲

第10章競爭格局

  • 概述
  • 主要企業策略/主要企業
  • 收益分析(2021-2023)
  • 市場佔有率分析(2023)
  • 企業評價矩陣:主要企業(2023年)
  • 企業評估矩陣:Start-Ups/中小企業(2023)
  • 競爭場景
  • 品牌/產品比較
  • 公司評價及財務指標
    • 財務指標
    • 公司評價

第11章 公司簡介

  • 主要企業
    • OLYMPUS CORPORATION
    • BOSTON SCIENTIFIC CORPORATION
    • MEDTRONIC PLC
    • STRYKER CORPORATION
    • COOK MEDICAL
    • FUJIFILM CORPORATION
    • CONMED CORPORATION
    • ETHICON (A JOHNSON & JOHNSON SUBSIDIARY)
    • MERIT MEDICAL SYSTEMS
    • STERIS PLC
    • KARL STORZ SE & CO. KG
  • 其他公司
    • SHAILI ENDOSCOPY
    • TAEWOONG MEDICAL CO., LTD.
    • HOBBS MEDICAL, INC.
    • PENTAX MEDICAL
    • ERBE ELEKTROMEDIZIN
    • AMBU A/S
    • CAPSOVISION, INC.
    • INTROMEDIC, INC.
    • VIMEX ENDOSCOPY
    • TRIVITRON HEALTHCARE
    • MEDI-GLOBE CORPORATION
    • SONOSCAPE MEDICAL CORP.
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
    • MEDSPIRA

第12章附錄

Product Code: MD 9132

The global Gastroenterology/Gastrointestinal Products Market is projected to reach USD 19.7 billion by 2029 from USD 14.7 billion in 2024, at a CAGR of 6.1% from 2024 to 2029. The market for gastroenterology and gastrointestinal products is driven by several factors, such as the growing incidence of GI disorders, improvements in technology, aging populations, rising healthcare costs, increased awareness and screening initiatives, rising R&D spending, the need for personalized medicine, and economic expansion in emerging markets. The GI product industry is dynamic and ever-evolving due to the combined influence of these drivers.

Scope of the Report
Years Considered for the Study2021-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsBy Device, Disease, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"The endoscopy segment from the devices segment accounted for the largest share during the forecast period."

The Gastroenterology/Gastrointestinal product market is divided into Endoscopy, Ablations systems, Motility testing, Stenting devices, Ph monitoring, and other devices. The endoscopy segment accounted for the largest share during the forecast period. Endoscopic techniques enable the removal of polyps, tissue biopsies, stent implantation, and tumor ablation, among other therapeutic and diagnostic treatments. These developments support endoscopy's increasing use for a range of gastrointestinal disorders.

"The GERD segment in the diseases segment accounted for the largest share during the forecast period.."

The increasing prevalence of GERD, driven by lifestyle factors, obesity, aging populations, and enhanced diagnostic and treatment options, is significantly boosting the share of the gastroenterology market. As awareness grows and technological advancements continue, the demand for gastroenterological products and services is expected to rise, further driving market growth. As the global population ages, the incidence of GERD increases. Older adults are more susceptible to GERD due to changes in esophageal motility and the function of the lower esophageal sphincter.

"APAC is estimated to register the highest CAGR during the forecast period."

The Gastroenterology/Gastrointestinal Products Market is divided into Five regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The Asia Pacific is witnessed to have the highest CAGR during the forecast period.. Many APAC countries, including Japan, South Korea, and China, are witnessing demographic shifts as their populations age. Older persons have a higher prevalence of diseases like GERD and complex healthcare needs.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia Pacific (25%), RoW(16%)

List of Companies Profiled in the Report

  • BOSTON SCIENTIFIC (U.S)
  • MEDTRONIC (U.S)
  • OLYMPUS CORPORATION (JAPAN)
  • STRYKER (U.S.)
  • GLOBUS MEDICAL (U.S.)
  • COOK MEDICAL (US)
  • ETHICON (SUBSIDIARY OF J&J)
  • FUJIFILM (JAPAN)
  • CONMED CORPORATION (US)
  • KARL STORZ (GERMANY)

Research Coverage

This report studies the Gastroenterology/Gastrointestinal Products Market based on devices, diseases, end-users and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Gastroenterology/Gastrointestinal Products Market. The report forecasts the revenue of the market segments to five major regions.

Reasons to Buy the Report

This report also includes.

  • Analysis of key drivers (increasing GI diseases, technological advancements) , restraints (Cost of the system), challenges(regulatory policies), and opportunities (Increase in the minimally invasive procedures) contributing to the growth of the Gastroenterology/Gastrointestinal Products Market.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Gastroenterology/Gastrointestinal Products Market.
  • Market Development: Comprehensive information on the lucrative emerging markets by devices, diseases, end-users and region.
  • Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Gastroenterology/Gastrointestinal Products Market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Gastroenterology/Gastrointestinal Products Market..

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE AND REGION (2023)
  • 4.3 GEOGRAPHIC SNAPSHOT OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of GI disorders
      • 5.2.1.2 Technological advancements in gastroenterology products
      • 5.2.1.3 Growing aging population
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Stringent regulatory policies for GI products
      • 5.2.2.2 Increasing healthcare costs
      • 5.2.2.3 Unfavorable healthcare reforms in US
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing preference for minimally invasive surgery
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Changing regulatory landscape
      • 5.2.4.2 Shortage of trained physicians and endoscopists
  • 5.3 INDUSTRY TRENDS
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Capsule endoscopy
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Laboratory testing
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Robotic surgery systems
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 PORTER'S FIVE FORCE ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 REGULATORY ANALYSIS
      • 5.7.1.1 North America
        • 5.7.1.1.1 US
        • 5.7.1.1.2 Canada
      • 5.7.1.2 Europe
      • 5.7.1.3 Asia Pacific
        • 5.7.1.3.1 Japan
        • 5.7.1.3.2 China
    • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 PATENT ANALYSIS
    • 5.8.1 PATENT PUBLICATION TRENDS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
    • 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.9 TRADE ANALYSIS
    • 5.9.1 HS CODES: GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS
    • 5.9.2 IMPORT DATA
    • 5.9.3 EXPORT DATA
  • 5.10 PRICING ANALYSIS
  • 5.11 REIMBURSEMENT ANALYSIS
  • 5.12 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 BUYING CRITERIA
  • 5.14 UNMET NEEDS ANALYSIS
  • 5.15 END-USER EXPECTATIONS
  • 5.16 ECOSYSTEM ANALYSIS
  • 5.17 CASE STUDY ANALYSIS
  • 5.18 SUPPLY CHAIN ANALYSIS
  • 5.19 INVESTMENT & FUNDING SCENARIO
  • 5.20 IMPACT OF GEN AI/AI ON GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET

6 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE

  • 6.1 INTRODUCTION
  • 6.2 ENDOSCOPY DEVICES
    • 6.2.1 FLEXIBLE ENDOSCOPES
      • 6.2.1.1 Advantages such as flexibility and ease of use to drive demand for flexible endoscopes
    • 6.2.2 RIGID ENDOSCOPES
      • 6.2.2.1 Ability of rigid endoscopes to provide vertical-axis images of internal organs to support market growth
    • 6.2.3 CAPSULE ENDOSCOPES
      • 6.2.3.1 Non-invasive nature of capsule endoscopes to drive adoption
    • 6.2.4 OTHER ENDOSCOPY DEVICES
  • 6.3 ABLATION DEVICES
    • 6.3.1 RADIOFREQUENCY ABLATION DEVICES
      • 6.3.1.1 Low cost of radiofrequency ablation to contribute to market growth
    • 6.3.2 MICROWAVE ABLATION DEVICES
      • 6.3.2.1 Advantages over RF ablation to ensure sustained demand for microwave ablation devices
    • 6.3.3 CRYOABLATION DEVICES
      • 6.3.3.1 Increasing cancer incidence to drive market for cryoablation devices
    • 6.3.4 LASER ABLATION DEVICES
      • 6.3.4.1 High efficacy and safety to drive adoption of laser/light ablation devices
    • 6.3.5 OTHER ABLATION DEVICES
  • 6.4 MOTILITY TESTING DEVICES
    • 6.4.1 ESOPHAGEAL MANOMETRY DEVICES
      • 6.4.1.1 Rising incidence of esophageal motility disorders to boost market growth
    • 6.4.2 4-HOUR PH IMPEDANCE TESTING DEVICES
      • 6.4.2.1 Ability to provide data useful for tailoring individualized treatment plans to favor market growth
    • 6.4.3 ANORECTAL MANOMETRY DEVICES
      • 6.4.3.1 Growing popularity of anorectal manometry devices for diagnosis of gastrointestinal problems to support market growth
    • 6.4.4 OTHER MOTILITY TESTING DEVICES
  • 6.5 BIOPSY DEVICES
    • 6.5.1 NEEDLE BIOPSY DEVICES
      • 6.5.1.1 Increasing screening of gastrointestinal diseases to aid growth
    • 6.5.2 OTHER BIOPSY DEVICES
  • 6.6 STENTING DEVICES
    • 6.6.1 BILIARY STENTS
      • 6.6.1.1 Increasing prevalence of bile duct cancer and chronic liver disease to drive growth
    • 6.6.2 COLONIC STENTS
      • 6.6.2.1 Rising demand for colonic stents due to high incidence of colorectal cancer to drive segmental growth
    • 6.6.3 DUODENAL STENTS
      • 6.6.3.1 Increasing prevalence of intestinal malignancy to boost adoption of duodenal stents
    • 6.6.4 PANCREATIC STENTS
      • 6.6.4.1 Rising number of ERCP and PTC procedures to drive market growth
    • 6.6.5 ESOPHAGEAL STENTS
      • 6.6.5.1 Increasing incidence of esophageal cancer to propel market growth
  • 6.7 PH MONITORING DEVICES
    • 6.7.1 ESOPHAGEAL PH MONITORING CATHETERS
      • 6.7.1.1 Growing sedentary lifestyles to drive demand
    • 6.7.2 WIRELESS PH MONITORING CAPSULES
      • 6.7.2.1 Reduced risk of open surgeries to boost market
    • 6.7.3 AMBULATORY PH MONITORING SYSTEMS
      • 6.7.3.1 Convenience and accuracy of ambulatory pH monitoring to drive market
  • 6.8 OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES
    • 6.8.1 GASTRIC BALLOONS
      • 6.8.1.1 Minimally invasive nature of gastric balloons to boost adoption
    • 6.8.2 GASTROINTESTINAL TUBES
      • 6.8.2.1 Rising incidence of diseases to drive need for gastrointestinal tubes
    • 6.8.3 HEMORRHOID TREATMENT DEVICES
      • 6.8.3.1 Rising cases of hemorrhoids to support market growth

7 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE

  • 7.1 INTRODUCTION
  • 7.2 GASTROINTESTINAL CANCERS
    • 7.2.1 CHANGING DIETS AND GROWING PREVALENCE OF OBESITY TO BOOST MARKET GROWTH
  • 7.3 GASTROESOPHAGEAL REFLUX DISEASE
    • 7.3.1 GROWING INCIDENCE OF GERD TO DRIVE MARKET GROWTH
  • 7.4 IRRITABLE BOWEL SYNDROME (IBS)
    • 7.4.1 GROWING IBS DISEASE BURDEN TO DRIVE DEMAND FOR GASTROINTESTINAL PRODUCTS
  • 7.5 INFLAMMATORY BOWEL DISEASE (IBD)
    • 7.5.1 GROWING USE OF CAPSULE ENDOSCOPES IN TREATING IBD TO FAVOR MARKET GROWTH
  • 7.6 OTHER DISEASES

8 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    • 8.2.1 HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL PROCEDURES IN HOSPITALS
  • 8.3 AMBULATORY SURGICAL CENTERS & INDEPENDENT SURGICAL CENTERS
    • 8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE MARKET GROWTH
  • 8.4 CLINICS
    • 8.4.1 GROWING NEED FOR CLINICAL SCREENING TO DIAGNOSE GASTROINTESTINAL DISEASES TO BOOST MARKET
  • 8.5 OTHER END USERS

9 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American market during forecast period
    • 9.2.3 CANADA
      • 9.2.3.1 Increased availability of funding and presence of research institutes to propel market
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Favorable reimbursement scenario and increased geriatric population to aid market growth
    • 9.3.3 UK
      • 9.3.3.1 Rising investments by hospitals in new and advanced gastroenterology/gastrointestinal products to augment market growth
    • 9.3.4 FRANCE
      • 9.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
    • 9.3.5 ITALY
      • 9.3.5.1 High per capita income and improved healthcare system to drive market
    • 9.3.6 SPAIN
      • 9.3.6.1 Growing prevalence of cardiovascular diseases to boost market growth
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Favorable medical device reimbursement policies and public health insurance schemes to aid market growth
    • 9.4.3 CHINA
      • 9.4.3.1 Increasing geriatric population and increase in domestic manufacturers for gastrointestinal products to support growth
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing incidence of diseases like diabetes to enhance market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 High incidence of cancer to propel market growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Increase in private healthcare investments and rise in medical tourism to aid market growth
    • 9.5.3 MEXICO
      • 9.5.3.1 Increased government investment in healthcare infrastructure and technological advancements to aid market growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 Increasing investment in healthcare infrastructure and growing medical tourism to propel market growth
    • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.3 REVENUE ANALYSIS, 2021-2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Disease footprint
      • 10.5.5.3 End-user footprint
      • 10.5.5.4 Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 PRODUCT LAUNCHES & APPROVALS
    • 10.7.2 DEALS
    • 10.7.3 EXPANSIONS
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPANY VALUATION & FINANCIAL METRICS
    • 10.9.1 FINANCIAL METRICS
    • 10.9.2 COMPANY VALUATION

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 OLYMPUS CORPORATION
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches & approvals
        • 11.1.1.3.2 Deals
        • 11.1.1.3.3 Expansions
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 BOSTON SCIENTIFIC CORPORATION
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches & approvals
        • 11.1.2.3.2 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 MEDTRONIC PLC
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product approvals
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 STRYKER CORPORATION
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product approvals
        • 11.1.4.3.2 Deals
        • 11.1.4.3.3 Expansions
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 COOK MEDICAL
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product launches & approvals
        • 11.1.5.3.2 Deals
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 FUJIFILM CORPORATION
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches & approvals
        • 11.1.6.3.2 Other developments
    • 11.1.7 CONMED CORPORATION
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
    • 11.1.8 ETHICON (A JOHNSON & JOHNSON SUBSIDIARY)
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product launches & approvals
    • 11.1.9 MERIT MEDICAL SYSTEMS
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product launches
    • 11.1.10 STERIS PLC
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
    • 11.1.11 KARL STORZ SE & CO. KG
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Deals
  • 11.2 OTHER PLAYERS
    • 11.2.1 SHAILI ENDOSCOPY
    • 11.2.2 TAEWOONG MEDICAL CO., LTD.
    • 11.2.3 HOBBS MEDICAL, INC.
    • 11.2.4 PENTAX MEDICAL
    • 11.2.5 ERBE ELEKTROMEDIZIN
    • 11.2.6 AMBU A/S
    • 11.2.7 CAPSOVISION, INC.
    • 11.2.8 INTROMEDIC, INC.
    • 11.2.9 VIMEX ENDOSCOPY
    • 11.2.10 TRIVITRON HEALTHCARE
    • 11.2.11 MEDI-GLOBE CORPORATION
    • 11.2.12 SONOSCAPE MEDICAL CORP.
    • 11.2.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
    • 11.2.14 MEDSPIRA

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 GLOBAL HEALTHCARE EXPENDITURES, BY REGION, 2022-2023
  • TABLE 3 ASIA PACIFIC: HEALTHCARE EXPENDITURE, BY COUNTRY, 2022-2023
  • TABLE 4 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 HS CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS
  • TABLE 11 IMPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 12 EXPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 13 AVERAGE SELLING PRICE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS, BY KEY PLAYER, 2023 (USD)
  • TABLE 14 AVERAGE SELLING PRICE OF GASTROINTESTINAL PRODUCTS, BY REGION, 2021-2023
  • TABLE 15 REIMBURSEMENT CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL PROCEDURES
  • TABLE 16 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: KEY CONFERENCES & EVENTS, 2024-2025
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
  • TABLE 18 KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
  • TABLE 19 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: UNMET NEEDS
  • TABLE 20 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: END-USER EXPECTATIONS
  • TABLE 21 CASE STUDY 1: AI-ENHANCED CAPSULE ENDOSCOPY FOR SMALL BOWEL DISEASE DETECTION
  • TABLE 22 CASE STUDY 2: RADIOFREQUENCY ABLATION FOR BARRETT'S ESOPHAGUS
  • TABLE 23 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: AI INTEGRATION
  • TABLE 24 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 25 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 26 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (THOUSAND UNITS)
  • TABLE 27 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CAPSULE ENDOSCOPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ENDOSCOPY DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 33 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, VOLUME DATA 2022-2029 (THOUSAND UNITS)
  • TABLE 34 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MICROWAVE ABLATION DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CRYOABLATION DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR LASER ABLATION DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ABLATION DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 41 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL MANOMETRY DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR 4-HOUR PH IMPEDANCE TESTING DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ANORECTAL MANOMETRY DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER MOTILITY TESTING DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 47 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR NEEDLE BIOPSY DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER BIOPSY DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 51 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (THOUSAND UNITS)
  • TABLE 52 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 BILIARY STENTS OFFERED BY PROMINENT PLAYERS
  • TABLE 54 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BILIARY STENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 COLONIC STENTS OFFERED BY PROMINENT PLAYERS
  • TABLE 56 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR COLONIC STENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 DUODENAL STENTS OFFERED BY PROMINENT PLAYERS
  • TABLE 58 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR DUODENAL STENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 PANCREATIC STENTS OFFERED BY PROMINENT PLAYERS
  • TABLE 60 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PANCREATIC STENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 ESOPHAGEAL STENTS OFFERED BY PROMINENT PLAYERS
  • TABLE 62 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL STENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 64 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL PH MONITORING CATHETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR WIRELESS PH MONITORING CAPSULES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY PH MONITORING SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTRIC BALLOONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL TUBES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HEMORRHOID TREATMENT DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 74 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL CANCERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD), BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 76 TYPES OF IBS WITH SEVERITY INDEX
  • TABLE 77 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR IRRITABLE BOWEL SYNDROME (IBS), BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR INFLAMMATORY BOWEL DISEASE (IBD), BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 81 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 96 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 97 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024
  • TABLE 98 LIST OF DEVICES THAT RECEIVED FDA APPROVALS BETWEEN 2020 AND 2023
  • TABLE 99 US: MACROECONOMIC INDICATORS
  • TABLE 100 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 101 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 102 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 105 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 109 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 110 CANADA: MACROECONOMIC INDICATORS
  • TABLE 111 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 112 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 113 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 118 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 120 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 121 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 122 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 130 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 131 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 132 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 133 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 140 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 141 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 142 UK: MACROECONOMIC INDICATORS
  • TABLE 143 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 144 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 145 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 152 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 153 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 154 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 155 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 163 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 164 ITALY: MACROECONOMIC INDICATORS
  • TABLE 165 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 166 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 171 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 174 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 175 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 176 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 177 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 181 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 183 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 185 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 186 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 187 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 REST OF EUROPE: : GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 194 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 195 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 196 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 202 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 206 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 207 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 208 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 209 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 210 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 217 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 218 CHINA: MACROECONOMIC INDICATORS
  • TABLE 219 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 220 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 223 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 224 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 227 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 228 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 229 INDIA: MACROECONOMIC INDICATORS
  • TABLE 230 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 231 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 233 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 234 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 235 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 236 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 237 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 238 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 239 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 240 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 241 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 242 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 243 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 245 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 247 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 248 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 249 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 250 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 251 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 252 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 253 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 254 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 255 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 260 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 261 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 262 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 263 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 265 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 268 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 271 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 272 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 273 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 275 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 277 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 279 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 280 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 281 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 282 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 283 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 284 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 285 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 286 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 287 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 289 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 292 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 293 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 294 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 295 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 296 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 297 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 298 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 299 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 300 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 301 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 302 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 303 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 304 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 305 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 306 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 307 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 308 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 309 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 310 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 311 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 312 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 313 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 314 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 315 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 316 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 317 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 318 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 319 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 320 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 321 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 322 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 323 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 324 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 325 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 326 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 327 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 328 GCC COUNTRIES GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 329 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 330 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 331 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 332 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022-2029 (USD MILLION)
  • TABLE 333 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 334 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 335 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 336 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 337 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 338 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 339 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 340 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022-2029 (USD MILLION)
  • TABLE 341 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 342 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DEGREE OF COMPETITION
  • TABLE 343 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DEVICE FOOTPRINT
  • TABLE 344 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DISEASE FOOTPRINT
  • TABLE 345 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: END-USER FOOTPRINT
  • TABLE 346 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: REGION FOOTPRINT
  • TABLE 347 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: KEY START-UPS/SMES
  • TABLE 348 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: PRODUCT LAUNCHES & APPROVALS, MAY 2020-MARCH 2024
  • TABLE 349 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DEALS, JANUARY 2020-FEBRUARY 2024
  • TABLE 350 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: EXPANSIONS, JANUARY 2020-FEBRUARY 2024
  • TABLE 351 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 352 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 353 OLYMPUS CORPORATION: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2020-AUGUST 2024
  • TABLE 354 OLYMPUS CORPORATION: DEALS, JANUARY 2020-AUGUST 2024
  • TABLE 355 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2020-AUGUST 2024
  • TABLE 356 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 357 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 358 BOSTON SCIENTIFIC CORPORATION: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2020- AUGUST 2024
  • TABLE 359 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2020-AUGUST 2024
  • TABLE 360 MEDTRONIC PLC: COMPANY OVERVIEW
  • TABLE 361 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 362 MEDTRONIC PLC: PRODUCTS APPROVALS, JANUARY 2020-AUGUST 2024
  • TABLE 363 MEDTRONIC PLC: DEALS, JANUARY 2020-AUGUST 2024
  • TABLE 364 STRYKER CORPORATION: COMPANY OVERVIEW
  • TABLE 365 STRYKER CORPORATION: PRODUCTS OFFERED
  • TABLE 366 STRYKER CORPORATION: PRODUCT APPROVALS, JANUARY 2020-AUGUST 2024
  • TABLE 367 STRYKER CORPORATION: DEALS, JANUARY 2020-AUGUST 2024
  • TABLE 368 STRYKER CORPORATION: EXPANSIONS, JANUARY 2020-AUGUST 2024
  • TABLE 369 COOK MEDICAL: COMPANY OVERVIEW
  • TABLE 370 COOK MEDICAL: PRODUCTS OFFERED
  • TABLE 371 COOK MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-AUGUST 2024
  • TABLE 372 COOK MEDICAL: DEALS, JANUARY 2020-AUGUST 2024
  • TABLE 373 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 374 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 375 FUJIFILM CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-AUGUST 2024
  • TABLE 376 FUJIFILM CORPORATION: OTHER DEVELOPMENTS, JANUARY 2020-AUGUST 2024
  • TABLE 377 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 378 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 379 ETHICON: COMPANY OVERVIEW
  • TABLE 380 ETHICON: PRODUCTS OFFERED
  • TABLE 381 ETHICON: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-AUGUST 2024
  • TABLE 382 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
  • TABLE 383 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
  • TABLE 384 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES, JANUARY 2020-AUGUST 2024
  • TABLE 385 STERIS PLC: COMPANY OVERVIEW
  • TABLE 386 STERIS PLC: PRODUCTS OFFERED
  • TABLE 387 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
  • TABLE 388 KARL STORZ SE & CO. KG: PRODUCTS OFFERED
  • TABLE 389 KARL STORZ SE & CO. KG: DEALS, JANUARY 2020-AUGUST 2024

List of Figures

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 5 TOP-DOWN APPROACH
  • FIGURE 6 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
  • FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2029): IMPACT LEVEL OF CAGR
  • FIGURE 8 CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 15 INCREASING PREVALENCE OF GI DISORDERS TO DRIVE MARKET GROWTH
  • FIGURE 16 ENDOSCOPY DEVICES ACCOUNTED FOR LARGEST SHARE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET IN 2023
  • FIGURE 17 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 18 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19 ADVANCEMENTS IN TECHNOLOGY, FOCUS ON PREVENTIVE CARE, AND SHIFT TOWARD PATIENT-CENTERED APPROACHES
  • FIGURE 20 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 21 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 22 GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2014-MARCH 2024)
  • FIGURE 23 TOP APPLICANT & OWNER (COMPANIES/INSTITUTIONS) PATENTS (JANUARY 2014-MARCH 2024)
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
  • FIGURE 25 KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
  • FIGURE 26 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 27 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 28 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: INVESTMENT & FUNDING SCENARIO, 2018-2023
  • FIGURE 29 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET SNAPSHOT
  • FIGURE 30 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET SNAPSHOT
  • FIGURE 31 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
  • FIGURE 32 REVENUE ANALYSIS FOR KEY PLAYERS IN GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET (2019-2023)
  • FIGURE 33 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GASTROENTEROLOGY/ GASTROINTESTINAL PRODUCTS MARKET (2023)
  • FIGURE 34 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 35 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY FOOTPRINT
  • FIGURE 36 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • FIGURE 37 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 38 EV/EBITDA OF KEY VENDORS
  • FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 40 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 41 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 43 STRYKER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 44 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 45 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 46 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2023)
  • FIGURE 47 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023)
  • FIGURE 48 STERIS PLC: COMPANY SNAPSHOT (2023)